These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 4696622)
1. Another disadvantage of intramuscular digoxin. Lewis WS; Doherty JE N Engl J Med; 1973 May; 288(20):1077. PubMed ID: 4696622 [No Abstract] [Full Text] [Related]
2. Plasma digoxin levels in normal human volunteers following chronic oral and intramuscular administration. Brown DD; Abraham GN J Lab Clin Med; 1973 Aug; 82(2):201-7. PubMed ID: 4737242 [No Abstract] [Full Text] [Related]
3. [Clinical experience with acetyl-digoxin (Sandolanid)]. Leibetseder F Wien Klin Wochenschr; 1972 Mar; 84(9):148-9. PubMed ID: 5012663 [No Abstract] [Full Text] [Related]
4. Serum digoxin studies in infants and children. Hayes CJ; Butler VP; Gersony WM Pediatrics; 1973 Oct; 52(4):561-8. PubMed ID: 4742251 [No Abstract] [Full Text] [Related]
5. Plasma digoxin after parenteral administration. Local reaction after intramuscular injection. Steiness E; Svendsen O; Rasmussen F Clin Pharmacol Ther; 1974 Sep; 16(3):430-4. PubMed ID: 4137884 [No Abstract] [Full Text] [Related]
6. Pain and CPK elevation after intramuscular digoxin. Greenblatt DJ; Duhme DW; Koch-Weser J N Engl J Med; 1973 Mar; 288(13):689. PubMed ID: 4687265 [No Abstract] [Full Text] [Related]